| 000 | 01654 a2200409 4500 | ||
|---|---|---|---|
| 005 | 20250513211231.0 | ||
| 264 | 0 | _c20000629 | |
| 008 | 200006s 0 0 eng d | ||
| 022 | _a0006-2952 | ||
| 024 | 7 |
_a10.1016/s0006-2952(99)00312-3 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aHuang, Z F | |
| 245 | 0 | 0 |
_aDifferential regulation of cyclooxygenase-2 (COX-2) mRNA stability by interleukin-1 beta (IL-1 beta) and tumor necrosis factor-alpha (TNF-alpha) in human in vitro differentiated macrophages. _h[electronic resource] |
| 260 |
_bBiochemical pharmacology _cJan 2000 |
||
| 300 |
_a187-94 p. _bdigital |
||
| 500 | _aPublication Type: Comparative Study; Journal Article; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, P.H.S. | ||
| 650 | 0 | 4 | _aCell Differentiation |
| 650 | 0 | 4 | _aCyclooxygenase 2 |
| 650 | 0 | 4 | _aDrug Synergism |
| 650 | 0 | 4 | _aGene Expression Regulation, Enzymologic |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aIn Vitro Techniques |
| 650 | 0 | 4 |
_aInterleukin-1 _xpharmacology |
| 650 | 0 | 4 |
_aIsoenzymes _xgenetics |
| 650 | 0 | 4 |
_aLipopolysaccharides _xpharmacology |
| 650 | 0 | 4 |
_aMacrophages _xdrug effects |
| 650 | 0 | 4 | _aMembrane Proteins |
| 650 | 0 | 4 |
_aProstaglandin-Endoperoxide Synthases _xgenetics |
| 650 | 0 | 4 |
_aRNA Stability _xdrug effects |
| 650 | 0 | 4 |
_aRNA, Messenger _xdrug effects |
| 650 | 0 | 4 | _aTranscriptional Activation |
| 650 | 0 | 4 |
_aTumor Necrosis Factor-alpha _xpharmacology |
| 700 | 1 | _aMassey, J B | |
| 700 | 1 | _aVia, D P | |
| 773 | 0 |
_tBiochemical pharmacology _gvol. 59 _gno. 2 _gp. 187-94 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1016/s0006-2952(99)00312-3 _zAvailable from publisher's website |
| 999 |
_c10762295 _d10762295 |
||